Clinical trials
HIV clinical trials
Below are recruiting hiv clinical trials, each written for real people, not researchers. We’re tracking 611 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06586151Recruiting
HIV prevention program for gender-diverse teens
This study tests a text-message program to help prevent HIV in teens who are transgender, non-binary, or gender-diverse. It aims to see if the program can support healthy choices and reduce risk.
San Clemente, CaliforniaAges 14–18 - NCT07433387RecruitingPhase 1/Phase 2
Study of a new HIV drug for people not on treatment
This trial tests a new injectable treatment called LP-98 for people with HIV who have never taken HIV medications before. It aims to see if the drug is safe and can help lower the virus in your body.
Tianjin, Tianjin MunicipalityAges 18–65 - NCT06924073Recruiting
Helping young people with HIV move to adult care
This study tests a program to help young people with HIV move from teen to adult care. If you are 10-24 and get HIV care at one of the study clinics, this program may support you during this transition.
AwendoAges 10 years+ - NCT07292584Recruiting
Digital toolkit to help women start PrEP
This trial tests a digital toolkit to help women start taking PrEP, a medication that prevents HIV. It looks at whether the toolkit makes it easier for women to take PrEP consistently.
Birmingham, AlabamaAges 18 years+ - NCT07293559Recruiting
Understanding infant feeding choices in women with HIV
This study looks at how women with HIV decide whether to breastfeed, and what support they get from healthcare providers and family. It aims to learn about their experiences and needs.
Los Angeles, CaliforniaAges Any age - NCT05728996Recruiting
Study of early HIV to guide future care
This study follows people with a very recent HIV infection and collects blood and other samples to learn more about the infection soon after it starts. It may help researchers better understand early HIV and improve future treatments.
Amsterdam, North HollandAges 18 years+ - NCT00767312Enrolling by invitation
Study how HIV multiplies during HIV drug treatment
This study looks at how HIV continues to multiply (or stays suppressed) while you are taking antiretroviral therapy, using blood samples. It may help researchers better understand what HIV is doing during treatment and why some people experience changes like viral rebound.
Bethesda, MarylandAges 18–99 - NCT07329166Recruiting
Reducing HIV treatment interruptions in Malawi
This study tests a program to help people in Malawi stay on their HIV treatment even when they travel or move around. Researchers want to know if extra support can prevent gaps in care.
LilongweAges 15 years+ - NCT07231640Recruiting
Improving PrEP care for clinic staff
This study looks at ways to improve PrEP (pre-exposure prophylaxis) care by helping clinic staff track and support patients better. It's for healthcare workers, managers, and data staff at certain PrEP clinics.
Birmingham, AlabamaAges 18 years+ - NCT07220278Recruiting
HIV treatment support study in Malawi
This study tests a program to help people living with HIV who have missed their recent treatment appointment get back on track. It aims to find better ways to support ongoing treatment.
LilongweAges 15 years+ - NCT06810973Enrolling by invitation
HIV and Substance Use Support for People Leaving Jail
This study helps people with HIV or high risk of HIV who have had substance use problems and are in jail or recently released. It tests a program called SUCCESS-E to support health and reduce drug use.
Atlanta, GeorgiaAges 18 years+ - NCT05785169Recruiting
Trial improves clinic support for people with HIV
This study works with specific Ryan White clinics to improve support and well-being for both patients and healthcare staff. It will help test whether an “all-facility” approach in participating clinics can create a better care experience.
New York, New YorkAges 18 years+ - NCT06848686Recruiting
HIV service ambassador program for people who use drugs
This trial trains people who use drugs to talk with friends in their social network about HIV testing and services. It aims to encourage more people to get tested and linked to care.
San Diego, CaliforniaAges 18 years+ - NCT07145164Enrolling by invitationPhase 2
IL-15 to boost HIV control after pausing daily meds
This study tests whether giving a small protein called IL-15 can help your immune system keep HIV under control after pausing your daily HIV medications. You will stop your meds for a short time under careful monitoring, and the hope is that your body might learn to fight HIV without daily pills.
San Francisco, CaliforniaAges 18–70 - NCT07077642Enrolling by invitation
Health needs check for people with HIV
This study tests a new survey tool to better understand the health needs of people living with HIV. It aims to include a mix of ages and genders to make sure the tool works for everyone.
Genova, GenovaAges 18 years+ - NCT07053527Enrolling by invitation
Welcome to PrEP School: Peer-led HIV Prevention Study
This study tests if peer educators can help more students start PrEP, a daily pill that prevents HIV. If you are a student at one of the four listed colleges, you may be able to join.
Atlanta, GeorgiaAges 18–26 - NCT06576648Recruiting
HIV prevention study for young transgender women in Thailand
This study aims to reduce HIV stigma and improve PrEP use among young transgender women in Thailand. It is testing a new program to help those who are not already taking PrEP consistently.
BangkokAges 18–29 - NCT07002866Recruiting
PrEP access and adherence study for young women in Uganda
This study tests a program to help adolescent girls and young women at high risk of HIV take PrEP consistently. It aims to improve access and adherence to PrEP, a daily pill that prevents HIV.
St Louis, MissouriAges 15–24 - NCT06955715Recruiting
Pasteurized donor milk for HIV-exposed babies: a pilot study
This study tests if pasteurized donor human milk is a safe and acceptable option for infants exposed to HIV. It may help families who cannot or choose not to breastfeed.
Saskatoon, SaskatchewanAges 15 years+ - NCT06951542Enrolling by invitation
Reducing HIV and mental health stigma in Malawi
This study tests a program to reduce stigma for people living with HIV who also have symptoms of depression. It aims to improve mental health and HIV outcomes.
MulanjeAges 18 years+ - NCT06890988Recruiting
Dental team study to help end HIV epidemic
This trial tests if training dental teams (dentists, hygienists, assistants, navigators) can help end the HIV epidemic by offering HIV testing and prevention in dental visits. You may be able to join if you work in a dental practice that is part of this study.
New York, New YorkAges 18 years+ - NCT06904456Recruiting
Advanced HIV study in Zambia for those starting HIV treatment
This study looks at people with advanced HIV disease during their first months on antiretroviral therapy (ART). It aims to understand and improve care for those who start treatment when their immune system is weak.
LusakaAges 18 years+ - NCT06894199Recruiting
Work2Prevent Plus: Helping young Black men into HIV care
This trial tests a program called Work2Prevent Plus, which aims to help young Black men who have sex with men get into HIV care by connecting them with job support. If you're 18-29, identify as Black or African American, and have had sex with another man, you may be eligible.
Chicago, IllinoisAges 18 years+ - NCT06902142Recruiting
HIV treatment study with Bictegravir medication monitoring
This study looks at how well HIV-1 patients take their medication (bictegravir/emtricitabine/tenofovir) and how that relates to how well the virus is controlled. It uses a special pill bottle cap that records when the bottle is opened, so the research team can see if the medicine is being taken as prescribed.
CaenAges 18 years+
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hiv?
- Yes. Clin2 currently lists 611 recruiting hiv studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hiv trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hiv trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.